Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba pri izdelavi farmacevtskih pripravkov in njihova uporaba pri terapiji
The present invention discloses new stable pentadecapeptide salts of formula (I): (I) SEQ&emsp；ID&emsp；NO&emsp；1 Gly&emsp；Glu&emsp；Pro&emsp；Pro&emsp；Pro&emsp；Gly&emsp；Lys&emsp；Pro&emsp；Ala&emsp；Asp&emsp；Asp&emsp；Ala 1&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；5&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；10&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp； Gly&emsp；Leu&emsp；Val&emsp；· n&emsp；BAA &emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；15 wherein n means 1, 2 or 3, and BAA means basic amino acid, a process for the preparation thereof, a process for the use thereof for the manufacture of pharmaceutical formulations in liquid and solid form and a use thereof for prevention, protection in treatment of diseases and disease conditions and for the preparation of formulations for use as food supplements.
